Acquisitions (Tables)

CanAm Care, LLC. [Member]

The final allocation of the $39,014 purchase price was:



Accounts receivable	$	3,568
Inventory	6,391
Property and equipment	91
Other assets	126
Deferred income tax assets	625
Goodwill	15,040
Intangible assets	15,830
Total assets acquired	41,671

Accounts payable	2,237
Other current liabilities	420
Total liabilities assumed	2,657
Net assets acquired	$	39,014

Intangible assets acquired in the acquisition were valued as follows:



Customer relationships	$	12,000
Developed product technology	1,600
Non-compete agreements	1,540
Trade name and trademarks	690
Total intangible assets acquired	$	15,830

Paddock Laboratories Inc [Member]

The following table summarizes the final fair values of the assets acquired and liabilities assumed related to the Paddock acquisition:



	Initial Valuation		Measurement Period Adjustments			Final Valuation
Accounts receivable	$	55,467	$	—		$	55,467
Inventory	57,540		—			57,540
Property and equipment	33,200		—			33,200
Other assets	1,743		—			1,743
Deferred income tax assets	20,863		(344		)	20,519
Goodwill	150,035		(1,170		)	148,865
Intangible assets	272,000		—			272,000
Total assets acquired	590,848		(1,514		)	589,334

Accounts payable	10,685		—			10,685
Other current liabilities	2,386		—			2,386
Accrued customer programs	26,926		(677		)	26,249
Accrued expenses	3,799		—			3,799
Total liabilities assumed	43,796		(677		)	43,119
Net assets acquired	$	547,052	$	(837	)	$	546,215

Intangible assets acquired in the acquisition were valued as follows:



Developed product technology	$	237,000
In-process research and development	35,000
Total intangible assets acquired	$	272,000

Paddock and CanAm Care [Member]

The following unaudited pro forma financial information presents results as if the acquisitions of CanAm and Paddock had occurred at the beginning of fiscal 2011:



(Unaudited)	Fiscal Year
	2012		2011
Net sales	$	3,208,313	$	3,023,849
Income from continuing operations	$	549,769	$	443,570
Basic earnings from continuing operations per share	$	4.47	$	3.64
Diluted earnings from continuing operations per share	$	4.43	$	3.59

PBM Holdings, Inc. [Member]

The following table summarizes the final fair values of the assets acquired and the liabilities assumed related to the PBM acquisition:



	Initial Valuation		Measurement Period Adjustments			Final Valuation
Cash	$	30,591	$	—		$	30,591
Accounts receivable	20,891		(1,998		)	18,893
Inventory	38,419		—			38,419
Property and equipment	62,084		—			62,084
Other assets	1,663		2,146			3,809
Deferred income tax assets	2,153		1,090			3,243
Goodwill	329,578		721			330,299
Intangible assets	382,500		—			382,500
Total assets acquired	867,879		1,959			869,838
Accounts payable	10,046		—			10,046
Other current liabilities	125		2,540			2,665
Deferred income tax liabilities	185		—			185
Accrued expenses	16,156		1,417			17,573
Total liabilities assumed	26,512		3,957			30,469
Net assets acquired	$	841,367	$	(1,998	)	$	839,369

Intangible assets acquired in the acquisition were valued as follows:



Customer relationships	$	250,000
Product formulations	107,000
Distribution agreements	18,000
Developed product technology	4,200
Trade names and trademarks	1,900
Non-compete agreement	1,400
Total intangible assets acquired	$	382,500

Orion Laboratories Pty Ltd. [Member]

The following table summarizes the final fair values of the assets acquired and the liabilities assumed related to the Orion acquisition:



	Initial Valuation		Measurement Period Adjustments			Final Valuation
Cash	$	671	$	—		$	671
Accounts receivable	4,631		(1,485		)	3,146
Inventory	4,484		—			4,484
Property and equipment	11,490		—			11,490
Other assets	110		—			110
Deferred income tax assets	322		1,602			1,924
Goodwill	16,566		(104		)	16,462
Other Intangible assets	15,600		—			15,600
Total assets acquired	53,874		13			53,887
Accounts payable	2,247		—			2,247
Other current liabilities	954		—			954
Deferred income tax liabilities	3		1,488			1,491
Taxes payable	1,173		10			1,183
Total liabilities assumed	4,377		1,498			5,875
Net assets acquired	$	49,497	$	(1,485	)	$	48,012

Intangible assets acquired in the acquisition were valued as follows:



Customer relationships	$	12,000
Non-compete agreements	2,418
Product formulations	1,182
Total intangible assets acquired	$	15,600

Vedants Drug & Fine Chemicals Private Ltd. [Member]

The purchase price of $11,500 was allocated as follows:



Cash	$	1,441
Accounts receivable	168
Inventory	2
Property and equipment	8,436
Goodwill	4,183
Total assets acquired	14,230
Accounts payable	171
Other liabilities	1,289
Noncontrolling interest	1,270
Total liabilities and equity assumed	2,730
Net assets acquired	$	11,500

Major Global Diagnostic Company [Member]

The purchase price of $4,610 was allocated as follows:



Inventory	$	1,346
Property and equipment	1,262
Intangible assets – Customer contracts	2,002
Total assets acquired	$	4,610

Local Pharmaceutical Company [Member]

The purchase price of $5,152 was allocated as follows:



Inventory	$	869
Property and equipment	600
Intangible assets – Customer contracts	3,683
Total assets acquired	$	5,152

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References+ Details